These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 16014541)
21. Investigation of the immunogenicity of a protein drug using equilibrium dialysis and liquid chromatography tandem mass spectrometry detection. Ji QC; Rodila R; Morgan SJ; Humerickhouse RA; El-Shourbagy TA Anal Chem; 2005 Sep; 77(17):5529-33. PubMed ID: 16131062 [TBL] [Abstract][Full Text] [Related]
22. A multiplexed immunoassay for detection of antibodies against avian influenza virus. Watson DS; Reddy SM; Brahmakshatriya V; Lupiani B J Immunol Methods; 2009 Jan; 340(2):123-31. PubMed ID: 19000692 [TBL] [Abstract][Full Text] [Related]
23. Development of an ICP-MS immunoassay for the detection of anti-erythropoietin antibodies. Lu Y; Wang W; Xing Z; Wang S; Cao P; Zhang S; Zhang X Talanta; 2009 May; 78(3):869-73. PubMed ID: 19269443 [TBL] [Abstract][Full Text] [Related]
24. Immunogenicity of biological therapeutics: from assay to patient. Krieckaert C; Rispens T; Wolbink G Curr Opin Rheumatol; 2012 May; 24(3):306-11. PubMed ID: 22388644 [TBL] [Abstract][Full Text] [Related]
25. Affinity capture elution bridging assay: A novel immunoassay format for detection of anti-therapeutic protein antibodies. Chen YQ; Pottanat TG; Carter QL; Troutt JS; Konrad RJ; Sloan JH J Immunol Methods; 2016 Apr; 431():45-51. PubMed ID: 26874304 [TBL] [Abstract][Full Text] [Related]
26. Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products. Shankar G; Devanarayan V; Amaravadi L; Barrett YC; Bowsher R; Finco-Kent D; Fiscella M; Gorovits B; Kirschner S; Moxness M; Parish T; Quarmby V; Smith H; Smith W; Zuckerman LA; Koren E J Pharm Biomed Anal; 2008 Dec; 48(5):1267-81. PubMed ID: 18993008 [TBL] [Abstract][Full Text] [Related]
27. Erythropoietin and its lost receptor. Sturiale A; Campo S; Crascì E; Coppolino G; Bolignano D; Grasso G; Buemi M Nephrol Dial Transplant; 2007 May; 22(5):1484-5. PubMed ID: 17267537 [No Abstract] [Full Text] [Related]
28. Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products. Koren E; Smith HW; Shores E; Shankar G; Finco-Kent D; Rup B; Barrett YC; Devanarayan V; Gorovits B; Gupta S; Parish T; Quarmby V; Moxness M; Swanson SJ; Taniguchi G; Zuckerman LA; Stebbins CC; Mire-Sluis A J Immunol Methods; 2008 Apr; 333(1-2):1-9. PubMed ID: 18275969 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates. Stubenrauch K; Wessels U; Lenz H J Pharm Biomed Anal; 2009 May; 49(4):1003-8. PubMed ID: 19250787 [TBL] [Abstract][Full Text] [Related]
30. Prediction of immunogenicity for therapeutic proteins: state of the art. De Groot AS; Moise L Curr Opin Drug Discov Devel; 2007 May; 10(3):332-40. PubMed ID: 17554860 [TBL] [Abstract][Full Text] [Related]
31. Biopharmaceutical drug discovery using novel protein scaffolds. Gill DS; Damle NK Curr Opin Biotechnol; 2006 Dec; 17(6):653-8. PubMed ID: 17055245 [TBL] [Abstract][Full Text] [Related]
32. Quantifying small numbers of antibodies with a 'near-universal' protein-DNA chimera. Burbulis I; Yamaguchi K; Yu R; Resnekov O; Brent R Nat Methods; 2007 Dec; 4(12):1011-3. PubMed ID: 17982460 [TBL] [Abstract][Full Text] [Related]
33. The long and difficult road to the diagnostic market: protein microarrays. Joos TO; Berger H Drug Discov Today; 2006 Nov; 11(21-22):959-61. PubMed ID: 17055403 [No Abstract] [Full Text] [Related]
34. Determinants of immunogenic response to protein therapeutics. Singh SK; Cousens LP; Alvarez D; Mahajan PB Biologicals; 2012 Sep; 40(5):364-8. PubMed ID: 22770604 [TBL] [Abstract][Full Text] [Related]
35. Prevalence of anti-erythropoietin antibodies in hemodialysis patients without clinical signs of pure red cell aplasia. Comparison between hypo- and normoresponsive patients treated with epoetins for renal anemia. Stoffel MP; Haverkamp H; Kromminga A; Lauterbach KW; Baldamus CA Nephron Clin Pract; 2007; 105(2):c90-8. PubMed ID: 17164586 [TBL] [Abstract][Full Text] [Related]
36. A chip-based miniaturized format for protein-expression profiling: the exploitation of comprehensively produced antibodies. Koga H; Kyo M; Usui-Aoki K; Inamori K Electrophoresis; 2006 Sep; 27(18):3676-83. PubMed ID: 16915563 [TBL] [Abstract][Full Text] [Related]
37. Simultaneous detection of antibodies to foot-and-mouth disease non-structural proteins 3ABC, 3D, 3A and 3B by a multiplexed Luminex assay to differentiate infected from vaccinated cattle. Clavijo A; Hole K; Li M; Collignon B Vaccine; 2006 Mar; 24(10):1693-704. PubMed ID: 16260073 [TBL] [Abstract][Full Text] [Related]
38. How to predict and prevent the immunogenicity of therapeutic proteins. Schellekens H Biotechnol Annu Rev; 2008; 14():191-202. PubMed ID: 18606364 [TBL] [Abstract][Full Text] [Related]
39. Anti-glomerular basement membrane antibodies in the diagnosis of Goodpasture syndrome: a comparison of different assays. Sinico RA; Radice A; Corace C; Sabadini E; Bollini B Nephrol Dial Transplant; 2006 Feb; 21(2):397-401. PubMed ID: 16234289 [TBL] [Abstract][Full Text] [Related]
40. Ultra-sensitive immunochromatographic assay for quantitative determination of erythropoietin. Lönnberg M; Drevin M; Carlsson J J Immunol Methods; 2008 Dec; 339(2):236-44. PubMed ID: 18951900 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]